Citadel Advisors
PPH icon

Citadel Advisors’s VanEck Pharmaceutical ETF PPH Stock Holding History

Citadel Advisors’s Portfolio PPH Stock Details PPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,200
Closed -$330K – 13955
2025
Q4 		$330K Buy
+3,200
New +$311K ﹤0.01% 9936
2025
Q3 		– Sell
-6,100
Closed -$537K – 13804
2025
Q2 		$537K Buy
6,100
+3,800
+165% +$329K ﹤0.01% 8459
2025
Q1 		$210K Buy
2,300
+100
+5% +$9.01K ﹤0.01% 10355
2024
Q4 		$190K Buy
2,200
+1,200
+120% +$109K ﹤0.01% 10541
2024
Q3 		$95K Sell
1,000
-300
-23% -$28.5K ﹤0.01% 11184
2024
Q2 		$119K Sell
1,300
-100
-7% -$8.93K ﹤0.01% 10663
2024
Q1 		$127K Buy
1,400
+1,100
+367% +$96.3K ﹤0.01% 11025
2023
Q4 		$24.4K Hold
300
– – ﹤0.01% 12453
2023
Q3 		$24K Sell
300
-2,600
-90% -$210K ﹤0.01% 12475
2023
Q2 		$228K Sell
2,900
-2,700
-48% -$211K ﹤0.01% 9589
2023
Q1 		$435K Buy
5,600
+5,400
+2,700% +$416K ﹤0.01% 8591
2022
Q4 		$15.5K Sell
200
-38,500
-99% -$2.84M ﹤0.01% 13321
2022
Q3 		$2.6M Buy
38,700
+11,700
+43% +$862K ﹤0.01% 5093
2022
Q2 		$2.08M Buy
+27,000
New +$2.11M ﹤0.01% 5473
2021
Q4 		– Sell
-3,800
Closed -$276K – 14519
2021
Q3 		$276K Buy
+3,800
New +$283K ﹤0.01% 11233
2021
Q2 		– Sell
-16,200
Closed -$1.12M – 14244
2021
Q1 		$1.12M Sell
16,200
-2,900
-15% -$200K ﹤0.01% 7832
2020
Q4 		$1.27M Buy
19,100
+13,300
+229% +$852K ﹤0.01% 6284
2020
Q3 		$361K Buy
+5,800
New +$367K ﹤0.01% 7822
2019
Q3 		– Sell
-5,400
Closed -$317K – 9630
2019
Q2 		$317K Sell
5,400
-6,100
-53% -$353K ﹤0.01% 7500
2019
Q1 		$698K Buy
+11,500
New +$680K ﹤0.01% 6221

Other funds holding PPH

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
BCIM
British Columbia Investment Management Victoria, British Columbia, Canada $17B AUM 31.69% 1-Year Est. Return
ERSOT
Employees Retirement System of Texas Austin, Texas $11.4B AUM 21.6% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
JSAM
J. Safra Asset Management New York $1.86B AUM 22.95% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
AT
Avalon Trust Santa Fe, New Mexico $1.45B AUM 35.31% 1-Year Est. Return

Citadel Advisors's PPH Position: Q1 2026 in Review

Citadel Advisors opened a new position in VanEck Pharmaceutical ETF (PPH) in Q1 2026: 67,086 shares worth $6.97M. The stake represents ﹤0.01% of the portfolio and ranks #3816 among its holdings. This is a return to the name: Citadel Advisors previously reported a position in PPH as recently as Q3 2025.

Citadel Advisors first reported a position in PPH in Q1 2014 and has held it in 46 quarters since. 147 funds tracked by Wall St. Rank hold PPH as of Q1 2026.

  • Citadel Advisors held 67,086 shares of VanEck Pharmaceutical ETF worth $6.97M as of Q1 2026.
  • VanEck Pharmaceutical ETF was a new Citadel Advisors position in Q1 2026.
  • VanEck Pharmaceutical ETF made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #3816 holding.
  • Citadel Advisors first reported a position in VanEck Pharmaceutical ETF in Q1 2014 and has held it in 46 quarters since.
  • 147 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.